The role of short-chain acyl-CoA dehydrogenase in human umbilical vein endothelial cells

The role of short-chain acyl-CoA dehydrogenase in apoptosis of human umbilical vein endothelial cells

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900021860

Enrollment

Unknown

Registered

2019-03-13

Start date

2019-03-13

Completion date

Unknown

Last updated

2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Remodeling

Interventions

Case series:No

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Newborn umbilical cord standards: 1. Healthy newborns; 2. Fresh intact cord blood is not taken; 3. The length is 20-25 cm. Umbilical cord preservation method: Store at a low temperature of 4°C in a sterile PBS solution containing heparin and Penicillin-streptomycin solution.

Exclusion criteria

Exclusion criteria: 1. Maternal abnormalities during pregnancy; 2. Newborns have abnormal indicators.

Design outcomes

Primary

Measure	Time frame
apoptosis;oxidative stress;	—

Countries

China

Contacts

Public ContactSigui Zhou

Department of Clinical Pharmacy, GuangDong Pharmaceutical University

susanzsg@163.com+86 13640843211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026